These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26584032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH.
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R, Rempp H, Syha R, Ketelsen D, Pereira PL, Claussen CD, Clasen S.
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [Abstract] [Full Text] [Related]

  • 6. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
    Wang K, Liu G, Li J, Yan Z, Xia Y, Wan X, Ji Y, Lau WY, Wu M, Shen F.
    Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A, Del Prete V, Antonino M, Crucinio N, Neve V, Di Leo A, Carr BI, Barone M.
    Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
    [Abstract] [Full Text] [Related]

  • 9. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 10. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
    Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC.
    J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K.
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 13. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY.
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
    Yin XY, Xie XY, Lu MD, Kuang M, Liu GJ, Xu ZF, Xu HX, Wang Z.
    Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
    [Abstract] [Full Text] [Related]

  • 15. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS.
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [Abstract] [Full Text] [Related]

  • 16. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.
    Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041
    [Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients.
    Song YG, Shin SW, Cho SK, Choi D, Rhim H, Lee MW, Kim YS, Park KB, Park HS, Choo SW, Do YS, Choo IW, Hyun D.
    Acta Radiol; 2015 Jan 03; 56(1):70-7. PubMed ID: 24518688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.